Gilead to enroll pediatric patients for late-stage remdesivir study

Drugmaker Gilead Sciences said on Wednesday it will soon begin enrollment of pediatric patients with moderate-to-severe COVID-19 in a late-stage study testing its experimental drug, remdesivir.


from RSSMix.com Mix ID 8260657 https://ift.tt/2zHpnTh

Comments

Post a Comment

Popular posts from this blog

CG: SF@LAD - 5/30/21

Condensed Game:Mauricio Dubón and Evan Longoria homered behind Kevin Gausman's six scoreless innings in the Giants' 5-4 win over the Dodgers from RSSMix.com Mix ID 8260652 https://ift.tt/3yRkPn2
Read more